Danaher (DHR) Cash from Operations Growth (1y) (2010 - 2026)
Powered by 
Analysis
Danaher (DHR) Cash from Operations Growth (1y) (2010 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Ops. Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 241.68 Bn | 237.61 Bn | 8.34 Bn | 51.89% |
| 2 | Danaher | 147.34 Bn | 142.99 Bn | 3.61 Bn | 14.65% |
| 3 | Agilent Technologies | 43.34 Bn | 41.59 Bn | 1.04 Bn | 43.37% |
| 4 | Illumina | 34.58 Bn | 33.41 Bn | 770.00 Mn | -14.10% |
| 5 | Revvity | 16.31 Bn | 15.29 Bn | 416.87 Mn | 42.90% |
| 6 | Bio-Techne | 11.28 Bn | 11.01 Bn | 211.39 Mn | -2.84% |
| 7 | Bio-Rad Laboratories | 10.16 Bn | 8.54 Bn | 345.80 Mn | -15.28% |
| 8 | Repligen | 9.77 Bn | 8.75 Bn | 110.04 Mn | 14.53% |
| 9 | 10x Genomics | 9.45 Bn | 8.90 Bn | 112.50 Mn | -4.15% |
| 10 | Bruker | 9.26 Bn | 9.04 Bn | 416.00 Mn | 39.29% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 26, 2026 | 14.65% |
| Mar 27, 2026 | 1.77% |
| Dec 31, 2025 | 4.85% |
| Sep 26, 2025 | 9.85% |
| Jun 27, 2025 | -5.58% |
| Mar 28, 2025 | -25.30% |
| Dec 31, 2024 | 24.71% |
| Sep 27, 2024 | -9.51% |
| Jun 28, 2024 | -26.43% |
| Mar 29, 2024 | -10.68% |
| Dec 31, 2023 | -36.28% |
| Sep 29, 2023 | -16.82% |
| Jun 30, 2023 | -3.70% |
| Mar 31, 2023 | -1.07% |
| Dec 31, 2022 | 8.92% |
| Sep 30, 2022 | -1.18% |
| Jul 1, 2022 | -5.66% |
| Apr 1, 2022 | 5.18% |
| Dec 31, 2021 | 5.04% |
| Oct 1, 2021 | 18.05% |